Cibus, Inc. (CBUS)

Market Cap	396.00M
Revenue (ttm)	1.82M
Net Income (ttm)	-267.63M
Shares Out	24.77M
EPS (ttm)	-25.95
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	121,290
Open	16.05
Previous Close	16.00
Day's Range	15.64 - 16.73
52-Week Range	8.90 - 38.85
Beta	1.95
Analysts	Strong Buy
Price Target	25.00 (+56.35%)
Earnings Date	May 6, 2024

About CBUS

Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Jul 20, 2017
• Employees: 183
• Stock Exchange: NASDAQ
• Ticker Symbol: CBUS

Financial Performance

In 2023, Cibus's revenue was $1.82 million, an increase of 1057.32% compared to the previous year's $157,000. Losses were -$267.63 million, 1484.4% more than in 2022.

Analyst Forecast

According to one analyst, the rating for CBUS stock is "Strong Buy" and the 12-month stock price forecast is $25.0.

Price Target

$25.0

(56.35% upside)

Analyst Consensus: Strong Buy